Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

AgeneBio enrols first patient in Phase III trial of AGB101

Histopathogic image of senile plaques seen in the cerebral cortex in a patient with Alzheimer’s disease. Credit: User: KGH.

  • AgeneBio

Go Top